ACS Applied Materials & Interfaces · 2022 · 42 citations · 59 references
Biomimetic nanozyme with natural enzyme-like activities has drawn extensive attention in cancer therapy, while its application was hindered by the limited catalytic efficacy in the complicated tumor microenvironment (TME). Herein, a hybrid biomimetic nanozyme combines polydopamine-decorated CuO with a natural enzyme of glucose oxidase (GOD), among which CuO is endowed with a high loading rate (47.1%) of GOD due to the elaborately designed hollow mesoporous structure that is constructed to maximize the cascade catalytic efficacy. In the TME, CuO could catalyze endogenous H<sub>2</sub>O<sub>2</sub> into O<sub>2</sub> for relieving tumor hypoxia and improving the catalytic efficacy of GOD. Whereafter, the amplified glucose oxidation induces starvation therapy, and the generated H<sub>2</sub>O<sub>2</sub> and H<sup>+</sup> enhance the catalytic activity of CuO. Significantly, the tumor-specific chemodynamic therapy (CDT) could be realized when CuO degraded into Cu<sup>2+</sup> in acidic and reductive TME. Furthermore, the photothermal therapy with high photothermal conversion efficiency (30.2%) is achieved under NIR-II laser (1064 nm) excitation, which could reinforce the generation of reactive oxygen species (•OH and •O<sub>2</sub><sup>-</sup>). The TME initiates the biochemical reaction cycle of CuO, O<sub>2</sub>, and GOD, which couples with an NIR-II-induced thermal effect to realize O<sub>2</sub>-promoted starvation and photothermal-chemodynamic combined therapy. This hybrid biomimetic nanozyme enlightens the further development of nanozymes in multimodal cancer therapy.
59
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Minfeng Huo, Liying Wang, Yu Chen et al. · Nature Communications · 2017 · 1.3K citations · Full text
In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy
Kelong Fan, Juqun Xi, Lei Fan et al. · Nature Communications · 2018 · 1K citations · Full text